NCT06332053View on ClinicalTrials.gov

A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Healthy Subjects
Interventions
DRUG

SY-5007

SY-5007 80 mg, Tablets, 2 discrete single doses at Day 1 and Day 11

DRUG

Itraconazole

Itraconazole 200 mg, Capsules, Day 8-Day 18

DRUG

SY-5007

SY-5007 160 mg, Tablets, 2 discrete single doses at Day 1 and Day 16

DRUG

Rifampin

Rifampin 600 mg, Capsules, Day 8-Day 21

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Shouyao Holdings (Beijing) Co. LTD

OTHER